Aquestive Therapeutics, Inc. (AQST)
3.99
+0.08
(+2.05%)
USD |
NASDAQ |
Jun 09, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics SG&A Expense (Quarterly) : 10.98M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Nektar Therapeutics | 13.44M |
| Crinetics Pharmaceuticals, Inc. | 50.83M |
| Talphera, Inc. | 2.298M |
| Aytu Biopharma, Inc. | 10.90M |
| Journey Medical Corp. | 10.11M |